Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asterasys CoXKRX:450950 -4.29%23 Days Payable is 48.80 as of Jun. 2026, which is 15% above its 10-year median of 42.59. GuruFocus rates XKRX:450950 with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Asterasys Co ranks worse than 67.21% on this metric.
The historical rank and industry rank for Asterasys Co's Days Payable or its related term are showing as below:
XKRX:450950'
s Days Payable Range Over the Past 10 Years
Min: 35.8 Med: 42.59 Max: 53.32
Current: 48.45
During the past 5 years, Asterasys Co's highest Days Payable was 53.32. The lowest was 35.80. And the median was 42.59.
XKRX:450950's Days Payable is ranked worse than 67.21% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.68
vs XKRX:450950: 48.45
Asterasys Co's Days Payable
increased
from Jun. 2025 (40.93) to Jun. 2026 (48.80).
It may suggest that Asterasys Codelayed paying its suppliers.
The historical data trend for Asterasys Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:450950 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Asterasys Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asterasys Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Asterasys Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Asterasys Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Asterasys Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asterasys Co (XKRX:450950) has a Days Payable of 48.80 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Asterasys Co and its competitors. This is 15% above median its historical median of 42.59. Over the past decade, Asterasys Co's Days Payable has ranged from 35.80 to 53.32. According to the industry distribution chart, Asterasys Co ranks #535 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 67.2%.
Is Asterasys Co's Days Payable too high?
Asterasys Co's current Days Payable of 48.80 is 15% above median its 10-year median of 42.59. Over the past 10 years, this metric has ranged from a low of 35.80 to a high of 53.32. The Medical Devices & Instruments industry median Days Payable is 68.68. Asterasys Co's value of 48.80 is 28.9% below this industry median. Based on the distribution chart, Asterasys Co ranks #535 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Asterasys Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Asterasys Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Asterasys Co ranks #535 out of 796 companies for Days Payable. This places Asterasys Co in the lower half of its industry. The industry median Days Payable is 68.68. Asterasys Co's value of 48.80 is 28.9% below this benchmark. Historically, Asterasys Co's own Days Payable has ranged from 35.80 to 53.32 over the past decade. While the company's 10-year median is 42.59 vs. the industry median of 68.68, Asterasys Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.68, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asterasys Co's current Days Payable of 48.80 is 28.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Asterasys Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asterasys Co's current Days Payable is 48.80, which is 15% above median its own 10-year median of 42.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asterasys Co stock overvalued right now?
Asterasys Co (XKRX:450950) has a current Days Payable of 48.80. The current Days Payable is 48.80, which is 15% above median its 10-year median of 42.59 and 28.9% below the Medical Devices & Instruments industry median of 68.68. Asterasys Co's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Asterasys Co (XKRX:450950), the current Days Payable is 48.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asterasys Co Ltd is a professional healthcare and biomedical corporation based in Korea. It is engaged in the Manufacture of electro-diagnostic and electro-therapeutic apparatuses featuring body composition analyzers such as the InBalance series and HIFU systems such as the Liftera series, it provides total solutions with healthcare, skincare, and IoT-oriented services that can connect with its product portfolio.
23GF Score
Get the complete analysis for XKRX:450950
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:450950 has been successfully added to your 
